Results 131 to 140 of about 6,214,933 (159)
Some of the next articles are maybe not open access.
CLN2 Disease: Current Understandings, Challenges, and Future Directions
Journal of Child NeurologyNeuronal ceroid lipofuscinosis type 2 (CLN2) disease is a rare neurodegenerative condition that rapidly progresses with language regression, loss of ambulation, blindness, intractable seizures, and premature death in childhood. Enzyme replacement therapy has transformed the clinical trajectory of CLN2 disease, and early genetic testing is crucial ...
Maria Shock +3 more
openaire +2 more sources
PD49 Social Preferences In HTA: A Pilot Analysis In CLN2 Disease
International Journal of Technology Assessment in Health Care, 2018Introduction:It is established that the current cost effectiveness health technology assessment (HTA) paradigm does not appropriately value rare disease technologies. Social willingness-to-pay (SWTP) has been suggested to be higher for rare disease technologies, it's inclusion into existing HTA framework could better reflect social preferences (SP) and
Sumeet Bakshi +7 more
openaire +1 more source
CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis).
Pediatric endocrinology reviews : PER, 2016CLN2 disease is an inherited metabolic storage disorder caused by the deficiency of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1). The disease affects mainly the brain and the retina and is characterized by progressive dysfunction of the central nervous system, leading to dementia, epilepsy, loss of motor function and blindness.
Alfried, Kohlschütter, Angela, Schulz
openaire +1 more source
Intrafamilial variability in late-onset CLN2 disease
Molecular Genetics and Metabolism, 2020Sharan Goobie +2 more
openaire +1 more source
LINCE project: A fast diagnosis of CLN2 disease
Molecular Genetics and Metabolism, 2020Pablo Crujeiras +4 more
openaire +1 more source
Possibilities for an early diagnosis of CLN2-disease
Molecular Genetics and Metabolism, 2016Simona Murko +5 more
openaire +1 more source
Expert opinion on the management of CLN2 disease
Molecular Genetics and Metabolism, 2016TOPÇU, MERAL +24 more
openaire +2 more sources
Loss of visual function associated with photoreceptor degeneration in CLN2 disease
Molecular Genetics and Metabolism, 2023Christina Ohnsman +6 more
openaire +1 more source
METHODS FOR TREATING CLN2 DISEASE IN PEDIATRIC SUBJECTS
2021JACOBY DAVID, HENSHAW JOSHUA
openaire +5 more sources

